Coeptis Therapeutics Holdings Inc. Warrant 2022-28.10.2027 on Coeptis Therapeutics Holdings Inc. COEPW 深 滬
等待開盤 04-06 09:30:00 美东时间
0.01
0.000
-0.99%
華盛通- 最 高0.01
- 今 開0.0093
- 成交量 8.40万股
- 最 低 0.009
- 昨 收 0.0101
- 總市值 0
- 52周最高 0.0454
- 市盈率 靜 --
- 換手率 Infinity.00%
- 52周最低 0.0042
- 委 比 0.00%
- 總股本 --
- 歷史最高 1.74
- 量 比 0.79
- 振 幅 9.90%
- 歷史最低 0.0042
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Coeptis Reprices Equity Awards and Accelerates Option Vesting
Coeptis Therapeutics Holdings ( ($COEP) ) has shared an update. On February 11,...
02-13 06:34
Coeptis Shareholders Approve Merger, Spin-Out and Rebranding
Coeptis Therapeutics Holdings ( ($COEP) ) has provided an announcement. At an A...
02-05 06:13
Coeptis Therapeutics Addresses Nasdaq Listing Compliance Deficiency
Coeptis Therapeutics Holdings ( ($COEP) ) just unveiled an update. On January 1...
01-17 06:03
Coeptis Therapeutics' SEC-Approved S-4 Clears Path For Z Squared Merger, Stockholder Vote Set For January 30
Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, , announced today that its registration statement on Form S-4 (File No. 333-288329)
01-06 21:23
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) announced that its registration statement on Form S-4, related to its merger with Z Squared Inc. (ZSQ), has been declared effective by the SEC. The company will hold its Annual/Special Meeting of Shareholders on January 30, 2026, and has begun mailing the definitive proxy statement/prospectus to its shareholders of record as of January 2, 2026. The combined company has applied to list its common ...
01-06 13:19
Coeptis Therapeutics Q2 EPS $(1.17) Up From $(1.60) YoY, Sales $200.681K
Coeptis Therapeutics (NASDAQ:COEP) reported quarterly losses of $(1.17) per share. This is a 26.88 percent increase over losses of $(1.60) per share from the same period last year. The company reported $200.681 thousand
2025-08-15 05:48
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT
NEW YORK, July 3, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...
2025-07-04 05:31
Coeptis Therapeutics Files Form S-4 With SEC For Proposed Merger With Z Squared
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of a registration statement on Form S-4 with the
2025-06-26 20:37
SNAP Biosciences & Monarch Therapeutics Partner To Advance Snap-Car NK Cell Therapy
SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc. (NASDAQ:COEP) and Monarch Therapeutics Inc., a biotechnology company pioneering next-generation immunotherapies, today announced a
2025-05-28 20:29
Dogecoin Up 9% In One Week: Is A Breakout Coming?
Dogecoin (CRYPTO: DOGE) is up 9% over the past week, with key technical signals suggesting a possible breakout.
2025-04-29 19:55
